Search form

Joseph Lazzarotti Discusses Implications of New FDA Approved Digital Pill

Joseph Lazzarotti discusses the first FDA approved drug with an embedded electronic sensor and concerns surrounding its security of patient data in "Amid Privacy Concerns, Medication Ushers In Brave New World of ‘Digital Medicine,’" published by the Health Care Compliance Association.






See AllRelated News

October 30, 2018
ABA Journal

Joseph Lazzarotti Discusses the Vulnerability of Devices to Data Security Breaches

October 30, 2018

Joseph Lazzarotti discusses data security risks created by easily accessible software and office devices in "Any piece of technology that stores information could be compromised—even obsolete devices that get thrown out with the garbage," published by ABA Journal.  Subscription may be required to view article Read More

August 14, 2018
The Washington Post

Jason Gavejian Discusses Implications of Recording Conversations in the Workplace

August 14, 2018

Jason Gavejian discusses implications of secretly recording conversations in the workplace in  "Can you record your boss at work without him or her knowing?" published by The Washington Post. Subscription may be required to view article Read More

July 9, 2018

Jason Gavejian, Joseph Lazzarotti and Mary Costigan Discuss Successful Compliance With GDPR

July 9, 2018

Jason Gavejian, Joseph Lazzarotti and Mary Costigan discuss steps for businesses to take in the age of GDPR in "How the GDPR gives new meaning to established privacy and security principles," published by EVERFI. Subscription may be required to view article Read More